AW is supported by the Wellcome Trust Strategic Award (grant 097377) and the MRC Centre for Medical Mycology (grant MR/N006364/1) at the University of Aberdeen.Peer reviewedPublisher PD

Warris, Adilia

Archives of Disease in Childhood

English

The newly recognised and emerging fungal species,Candida auris, has caused worldwide invasive infections and has been implicated in difficult to control hospital outbreaks. Challenges are encountered in the correct identification of this fungus as commonly used phenotypic and biochemical methods fail to differentiateC. aurisfrom otherCandidaspecies. Its resistance profile, over 90% of isolates are fluconazole resistant and 35% are resistant to amphotericin, confronts clinicians with the restricted arsenal of antifungals and concerns about optimal treatment. The very firstC. aurisisolate was recovered from a paediatric patient in retrospect. Although infections with the more antifungal-resistantCandidaspecies are less frequently observed in paediatric patients, this seems to be different forC. aurisinfections.</jats:p

Adilia Warris

Crossref

<i>Candida auris</i>, what do paediatricians need to know?

AW is supported by the Wellcome Trust Strategic Award (grant 097377) and the MRC Centre for Medical Mycology (grant MR/N006364/1) at the University of Aberdeen.Peer reviewe

Aberdeen University Research

Candida auris, what do paediatricians need to know?

https://aura.abdn.ac.uk/bitstream/2164/10194/3/Candida_auris_what_do_paediatricians_need_to_know.pdf

Candida auris, what do paediatricians need to know?

Abstract

Similar works

Full text

Available Versions

Crossref

Aberdeen University Research